News Headline Summary

For Seattle Genetics (SGEN), Health Canada OKs Adcetris for treatment of relapsed Hodgkin Lymphoma

Reaction details:

- Co. shares moved 0.8% higher in reaction to this news to hit a high at USD 29.78; trades USD 29.72 last.

Print 19:09, 01 Feb 2013 - US Equities - Source: Newswires